Fig. 2From: Roxadustat alleviates the inflammatory status in patients receiving maintenance hemodialysis with erythropoiesis-stimulating agent resistance by increasing the short-chain fatty acids producing gut bacteriaChanges of hemoglobin concentration. W: weeks since application of roxadustatBack to article page